Sushama Kattinakere Sreedhara, MBBS, MSPH

Research Scientist
Brigham and Women's Hospital/Harvard Medical School, United States

Disclosure information not submitted.

Presentation(s):

• 1A-04 - Comparative Effectiveness of Current Glucose-Lowering Medications in Type 2 Diabetes Mellitus: Emulation of a modified GRADE trial

  Sunday, August 24, 2025
  11:15 AM - 11:30 AM ET

• 3A-01 - Cardiovascular Effectiveness of Semaglutide: Using Real-World Data to Predict Findings of the Ongoing SOUL Cardiovascular Outcomes Trial

  Monday, August 25, 2025
  8:15 AM - 8:30 AM ET

• 6C-03 - Using Real-World Data to Predict Findings of an Ongoing Phase IV Trial: Glycemic Control of Semaglutide vs Standard of Care

  Tuesday, August 26, 2025
  2:00 PM - 2:15 PM ET